Warning and Advisories for Healthcare Providers
>
Letters to Healthcare Providers
Letters to Healthcare Providers
New Measures to Minimise Known Heart Risks of Hydroxyzine-containing Medicines (Letter to Healthcare Professionals)
Attachment:
New Measures to Minimise Known Heart Risks of Hydroxyzine-containing Medicines
Related Information:
Canada: ATARAX (hydroxyzine) - Risk of QT Prolongation and Torsade de Pointes
Posted 2016-06-07
Singapore: Atarax (hydroxyzine) – New restrictions for hydroxyzine-containing me...
Posted 2015-08-18
The United Kingdom: Drug safety update: Hydroxyzine (Atarax, Ucerax): risk of QT...
Posted 2015-04-30
European Union: New restrictions to minimise the risks of effects on heart rhyth...
Posted 2015-03-28
European Union: PRAC recommends new measures to minimise known heart risks of hy...
Posted 2015-02-14
European Union: Review of hydroxyzine-containing medicines started
Posted 2014-05-09